Vaxart, Inc. (VXRT) › Total LiabilitiesVaxart, Inc. (VXRT) — Total LiabilitiesAnnual figures by period end, from SEC filings.2010-12-25: $53.30M2011-12-31: $39.09M2012-06-30: $10.00M2013-06-30: $17.80M2014-06-30: $27.10M2015-06-30: $9.90M2016-06-30: $26.50M2017-06-30: $21.40M2017-12-31: $43.24M2018-12-31: $23.99M2019-12-31: $24.08M2020-12-31: $29.18M2021-12-31: $33.64M2022-12-31: $43.25M2023-12-31: $34.02M2024-12-31: $107.46M2025-12-31: $98.28M$98.28M2010-12-25Total Liabilities (USD)2025-12-31Period endedTotal LiabilitiesChange YoYSource filing2025-12-31$98.28M-8.5%2026-03-13Balance as of period end2024-12-31$107.46M+215.8%2026-03-13Balance as of period end2023-12-31$34.02M-21.3%2025-03-20Balance as of period end2022-12-31$43.25M+28.6%2024-03-14Balance as of period end2021-12-31$33.64M+15.3%2023-03-15Balance as of period end2020-12-31$29.18M+21.2%2022-02-24Balance as of period end2019-12-31$24.08M+0.4%2021-02-25Balance as of period end2018-12-31$23.99M-44.5%2020-03-19Balance as of period end2017-12-31$43.24M—2019-02-06Balance as of period end2017-06-30$21.40M-19.2%2017-09-01Balance as of period end2016-06-30$26.50M+167.7%2017-09-01Balance as of period end2015-06-30$9.90M-63.5%2016-09-13Balance as of period end2014-06-30$27.10M+52.2%2015-09-11Balance as of period end2013-06-30$17.80M+78.0%2014-09-30Balance as of period end2012-06-30$10.00M—2013-09-27Balance as of period end2011-12-31$39.09M-26.7%2012-03-14Balance as of period end2010-12-25$53.30M—2012-03-14Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)